Literature DB >> 30402792

Why should we be concerned about a "g"?

Savvas Frangos1, John R Buscombe2.   

Abstract

Mesh：

Year:  2018        PMID： 30402792     DOI： 10.1007/s00259-018-4204-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  Theragnostic imaging for radiation oncology: dose-painting by numbers.

Authors:  Søren M Bentzen
Journal:  Lancet Oncol       Date:  2005-02       Impact factor: 41.316

2.  Nothing new under the nuclear sun: towards 80 years of theranostics in nuclear medicine.

Authors:  Frederik A Verburg; Alexander Heinzel; Heribert Hänscheid; Felix M Mottaghy; Markus Luster; Luca Giovanella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-06       Impact factor: 9.236

Review 3.  Theranostics: combining imaging and therapy.

Authors:  Sneha S Kelkar; Theresa M Reineke
Journal:  Bioconjug Chem       Date:  2011-08-29       Impact factor: 4.774

4.  The language of medicine.

Authors:  Henrik R Wulff
Journal:  J R Soc Med       Date:  2004-04       Impact factor: 18.000
  4 in total
  6 in total

1.  The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up.

Authors:  Johanna Maffey-Steffan; Lorenza Scarpa; Anna Svirydenka; Bernhard Nilica; Christian Mair; Sabine Buxbaum; Jasmin Bektic; Elisabeth von Guggenberg; Christian Uprimny; Wolfgang Horninger; Irene Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-27       Impact factor: 9.236

2.  Developments toward the Implementation of 44Sc Production at a Medical Cyclotron.

Authors:  Nicholas P van der Meulen; Roger Hasler; Zeynep Talip; Pascal V Grundler; Chiara Favaretto; Christoph A Umbricht; Cristina Müller; Gaia Dellepiane; Tommaso S Carzaniga; Saverio Braccini
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

3.  Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma Engineering.

Authors:  Camille M Le Gall; Johan M S van der Schoot; Iván Ramos-Tomillero; Melek Parlak Khalily; Floris J van Dalen; Zacharias Wijfjes; Liyan Smeding; Duco van Dalen; Anna Cammarata; Kimberly M Bonger; Carl G Figdor; Ferenc A Scheeren; Martijn Verdoes
Journal:  Bioconjug Chem       Date:  2021-01-21       Impact factor: 4.774

Review 4.  Radiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging.

Authors:  Heying Duan; Andrei Iagaru; Carina Mari Aparici
Journal:  Nanotheranostics       Date:  2022-01-01

5.  Screening for regenerative therapy responders in heart failure.

Authors:  Satsuki Yamada; Ryounghoon Jeon; Armin Garmany; Atta Behfar; Andre Terzic
Journal:  Biomark Med       Date:  2021-06-25       Impact factor: 2.851

6.  NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype.

Authors:  Mahmoud H Elbatreek; Sepideh Sadegh; Elisa Anastasi; Emre Guney; Cristian Nogales; Tim Kacprowski; Ahmed A Hassan; Andreas Teubner; Po-Hsun Huang; Chien-Yi Hsu; Paul M H Schiffers; Ger M Janssen; Pamela W M Kleikers; Anil Wipat; Jan Baumbach; Jo G R De Mey; Harald H H W Schmidt
Journal:  PLoS Biol       Date:  2020-11-10       Impact factor: 8.029
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.